Tag Archive for: CBD oil

NutraFuels, Inc. Tests Confirm High Quality Proprietary Ultra Shear Technology Platform

/in

To read this press release on OTCMarkets.com visit:

NutraFuels, Inc. Tests Confirm High Quality Proprietary Ultra Shear Technology Platform

Coconut Creek FL, Feb. 22, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — NutraFuels, Inc. fka NutraLife BioSciences, Inc. (OTCQB: NTFU) (NTFU) and Pressure BioSciences, Inc. (OTCQB: PBIO) (PBI) (together, the “Companies”), in a joint venture, today announce that analytical tests on Hemp-derived CBD oil processed by PBI’s Ultra Shear Technology™ (UST) platform confirm that: (i) UST processing results in the development of a true CBD oil nanoemulsion, and (ii) CBD is neither lost nor modified during the UST process (> 99% recovery).

The proprietary UST platform combines ultra-high pressure with extreme shearing forces to create very small, nano-scale mixtures of fluids that otherwise do not mix, resulting in a highly stable homogenized solution called nanoemulsions.

Dr. Vera Gross, Senior Scientist R&D at PBI, commented: “To determine if the UST process resulted in a loss or modification of CBD during processing, we enlisted the help of our collaborator NutraFuels, Inc. NTFU has an FDA-inspected, highly-qualified analytical laboratory with state-of-the-art equipment and well-trained chemists with years of experience in laboratory testing.”

For many oil-based nutritional and therapeutic products, such as CBD-infused nutraceuticals, nanoemulsions offer superior water solubility and increased bioavailability for improved absorption. Consequently, there is a significant need to develop reliable, scalable methods to process CBD oil into high-quality nanoemulsions, with minimal loss of CBD during the process.

Mr. Cooper Dodd, an R&D Scientist at NTFU, said: “Using a powerful laboratory method called HPLC to measure the concentrations of CBD and potential impurities, we determined that no appreciable amount of CBD was lost during the UST process. These results compare well to our standard processing method of ultrasonication, which can carry a risk of measurable loss of CBD, and sometimes create the appearance of impurities if not performed properly. While there is more work to be done, as a nutraceutical manufacturer with products already on the market, we see these results as a robust leap towards better optimization of our CBD-enhanced products.”

Dr. Gross, Director of Applications Development from PBI, added: “To determine if UST processing of CBD oil generates true nanoemulsions, we asked an independent, university-affiliated laboratory to determine the size of oil droplets in post-UST processed material using a universally-accepted sizing method called DLS. Their results showed that post-UST processed oil droplets were approximately 65 nm in size, well within the range of 20-200 nm generally accepted as defining a true nanoemulsion (Nano- and Microscale Drug Delivery Systems, 2017).”

Professor Keith Warriner, Professor of Food Science at the University of Guelph, and a recognized expert in the cannabis industry, commented: “The data disclosed today on UST-generated nanoemulsions of CBD oil are very impressive. Creating nanoemulsions of CBD oil with full preservation of CBD throughout the process, while not generating impurities, remains a significant challenge in the industry. These data offer great promise to the future.”

Professor Warriner continued: “Although there is great excitement over CBD-infused edibles and beverages, and rightfully so, I believe that CBD-infused topicals may be an even greater market for CBD products in the near future. However, to be successful, it is imperative that topicals be highly stable, bioavailable and readily absorbent nanoemulsions. After a review of the data released today, the UST process appears to be a leading candidate to fill that need.”

Dr. Bradford A. Young, Chief Commercial Officer of PBI, commented: “We were very excited to share the news just last week of PBI’s visually obvious successful production of water-soluble CBD Oil. However, the addition of these scientific validations of our successful achievement of creating nanoemulsions by the UST platform, and our preservation of CBD levels all the way through to the finished product are frankly the crowning touch to the news of these accomplishments.  We believe our proprietary Ultra Shear Technology will be a pivotal change agent strongly affecting the future of many major existing product areas, spanning foods, nutraceuticals, therapeutics, cosmetics, lubricants, paints, and other industries.”

About NutraFuels, Inc.

NutraFuels, Inc. fka NutraLife BioSciences, Inc. was founded in 2010 and has evolved into a branded and private label developer, distributor and Food and Drug Administration registered (FDA) manufacturer. NTFU’s products include a range of nutraceutical, wellness, and CBD products as well as a cosmetics line. NutraFuels’ manufacturing process received the Good Manufacturing Processes Standard (GMP) certification. Its products adhere to high manufacturing standards throughout every step of the manufacturing and extraction process. NTFU’s product testing and research and development are conducted by four chemists under the direction of NTFU’s founder and Chief Executive Officer, Edgar Ward.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO ’s primary focus is in the development of high pressure-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, food science, soil & plant biology, forensics, and counter-bioterror applications. Additionally, PBIO is actively expanding the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired protein disaggregation and refolding technology from BaroFold, Inc. to allow entry into the biologics manufacturing and contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

Forward-Looking Statements

This press release contains forward-looking statements about NutraFuels, Inc. and Pressure BioSciences, Inc. (collectively the “Companies”). These statements relate to future events or the Companies’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause each of the Companies industry results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. The Companies have based these forward-looking statements largely on their current expectations and projections about future events and financial trends that the Company believes may affect their respective financial condition, results of operations, business strategy, and financial needs. These statements are only predictions based on each of the Companies current expectations and projections about future events. Investors should not place undue reliance on these statements. In evaluating these statements, Investors should specifically consider various factors. Actual events or results may differ materially. These and other factors may cause the Companies’ actual results to differ materially from any forward-looking statement. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in each of the Companies’ Annual Reports and other reports filed from time to time with the Securities & Exchange Commission (SEC). More detailed information about these risk factors are set forth in the Companies’ filings with the SEC. The Companies encourage Investors to review these risk factors. The Companies undertake no obligation to update any of the information included in this release, except as otherwise required by law.

Selling cannabis or hemp on Times Square? Florida company makes marketing history

/in

Check out our news article on FloridaPolitics.com

While CBS still won’t run medical marijuana advertisements during the Super Bowl, a Florida company just ran the first-ever ads for cannabis-based products in Times Square.

NutraFuels, a nutraceutical manufacturing company with a line of hemp-derived CBD products under the brand NutraHempCBD (www.nutrahempcbd.com) was in the first digital billboard cannabis campaign in the famed intersection.

“This ad campaign was our way to celebrate the deregulation of hemp and create awareness of its health and wellness benefits,” said Edgar Ward, president and CEO of NutraFuels.

While companies with hemp and cannabis products in the past have tried to buy ad space in Times Square before, the marketing debuted concurrently with a change in the law.

Until this year, federal law technically classified all parts of the cannabis plant as marijuana, a scheduled narcotic. But the 2018 Farm Bill, as explained by the Billings Institute, differentiated hemp, a part of the plant containing less than 0.3 percent tetrahydrocannabinol. Better known as THC, that’s the stuff that gets people high.

“This campaign was our way of celebrating the Farm Bill and the deregulation of hemp,” said NutraFuels spokeswoman Chloe Sommers.

While the federal government long turned a blind eye to the sale of hemp and CBD oil, which can be sold in all 50 states, major media companies would not accept an advertisement for a product still technically prohibited by law.

It’s much the same reasoning that led CBS to reject an advertisement for Acreage Holdings, which sells medical marijuana, on the grounds the government still considers the sale of the product a crime.

But after the deregulation of hemp and CBD, Honeysuckle Magazine, a lifestyle magazine that regularly writes about the organic products, got approval to run a Times Square billboard campaign.

“It sounded interesting to me, so I jumped on the chance,” said Ronit Pinto, Honeysuckle owner. She offered space to many of advertisers working with her company, and many cannabis-related brands took part, including NutraFuels.

It turns out, the campaign marked the first time anyone sold cannabis-based products like hemp and CBD on a Times Square billboard.

“We started realizing what a great opportunity this involved for a lot of our brand partners, and just kept buying more time,” she said. “It became a huge thing.”

NutraFuels advertised its in-house CBD product NutraHempCBD. The ads provided tremendous exposure for the Coconut Beach-beached company, which employs about 12 people.

The Florida business remains one of the companies that’s continued to participate in the campaign as ad buys stretched into February.

The campaign still faces certain restrictions, Pinto said. There can’t be any pictures of the actual cannabis plant.

Advertisements also can’t show drug paraphernalia as the content must focus on those cannabis products legal under the new farm bill.

But the high-profile advertising could mark the first entry into mainstream marketing for a growing cannabis industry. Maybe the Super Bowl in 2020 will see such products promoted in commercial breaks.

“It’s the right thing to do,” Sommers said. “If you are doing the right thing and doing it by the rules, you should be able to market your product and be seen. CBS is buying into a stigma that’s actually flawed.”

“When it comes to cannabis, until the federal cannabis laws change like the hemp laws were, national media companies will be unlikely to accept their advertising,”  said NutraFuels spokesperson Chloe Sommers. “This positions CBD products well and it looks like it will only get better with time.

“When it comes to cannabis, until the federal cannabis laws change like the hemp laws were, national media companies will be unlikely to accept their advertising. This positions CBD products well and it looks like it will only get better with time.”

NutraFuels, Inc. (NTFU: OTC MARKETS), Makes Strides Towards Becoming Fully-Integrated in the Hemp-Derived CBD Sector, Forms a Strategic Partnership With a Maryland Based Botanical Products Processor

/in

To read this press release on OTCMarkets.com visit:

NutraFuels, Inc. (NTFU: OTC MARKETS), Makes Strides Towards Becoming Fully-Integrated in the Hemp-Derived CBD Sector, Forms a Strategic Partnership With a Maryland Based Botanical Products Processor

Coconut Creek, Florida, Nov. 20, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Through its wholly-owned subsidiary, Precision Analytic Testing, NTFU has entered into an agreement with a Maryland based Botanical Products Processor to refine, distill and process Crude US Grown Hemp Oil into finished CBD-rich oil at its established Cambridge, MD facility. The agreement will enable NTFU to offer and utilize cultivation, processing, and various forms of testing and procedures for bulk crude CBD oil into refined full-spectrum oil, distillate, and pure CBD in the form of isolate at the Processor’s Rural Maryland Council supported facilities. This Hemp Processor relationship will provide NTFU with a supply of finished CBD products and quality control of the processing of raw materials and finished CBD products in the hemp-CBD sector.

“We are pleased to announce this strategic alliance,” said Edgar Ward, CEO, and Founder of NutraFuels Inc. “This expansion ensures our supply as well as provides an additional revenue stream for NTFU as we strive to establish quality assurance and develop a gold standard in the hemp-derived CBD chain.”

NutraFuels, Inc is a fully reporting company with a class of securities registered with the U.S. Securities & Exchange Commission (“SEC”). As reported in its Form 8-K filed with the SEC on November 13, 2018, NTFU recently announced its financial results for the three (3) and nine (9) month period ended September 30, 2018 with revenue of $1,062,146 and $2,870,462 respectively compared to $652,385 and $1,027,727 for the three (3) and nine (9) month period ended September 30, 2017. NTFU’s filings with the SEC can be viewed at www.sec.gov. NTFU’s CBD products and information about the company’s direct sales program can be found online at www.nutrahempcbd.com and by following the company on Instagram.

Forward Looking Statements

This communications contains statements of a forward-looking nature. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as “may,” “will,” “except,”, “intends”, “anticipate,” “aim,” “estimate,” “plan,” “believe,” “is/are likely to,” “future” or other similar expressions. NutraFuels, Inc. (“NTFU” or the “Company”) has based these forward-looking statements largely on the Company’s current expectations and projections about future events and financial trends that the Company believes may affect Company’s financial condition, results of operations, business strategy and financial needs. There is no assurance that Company’s current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the Section entitled “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 filed with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law.

Attachment